Journal of Clinical Pharmacy and Therapeutics · 2010 · 31 citations · 17 references
MedicineDermatologyPediatricsHypersensitivityImmunopathologyPediatric RheumatologyDrug AllergyInflammatory Skin DisordersJuvenile Idiopathic ArthritisAtypical LymphocytesDress SyndromeDrug-induced Hypersensitivity SyndromeDrug-induced Rash With EosinophiliaDrug-induced Skin HypersensitivityEosinophilic DermatosisEosinophilic Skin DisordersMaculopapular Drug Eruption
DRESS-syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) is a severe drug-induced hypersensitivity syndrome characterized by diffuse maculopapular rash, lymphadenopathy, multivisceral involvement, eosinophilia and atypical lymphocytes with a mortality rate of 10-40% (Seminars in Cutaneous Medicine and Surgery, 1, 250). It is described in adults treated with aromatic antiepileptics and less frequently with sulphonamides, and non-steroidal anti-inflammatory drugs (Clinics in Dermatology, 23, 171; Pediatrics, 108, 485). We report on an 11-year-old Caucasian boy hospitalized with a skin eruption, lymphadenopathy, acute hepatitis, renal tubular involvement, haematological abnormalities and human-herpevirus-6 reactivation, treated with sulfasalazine and naproxen for juvenile idiopathic arthritis (JIA). This is the first report in children with rheumatic disease and highlights the possibility of sulfasalazine and naproxen-induced-DRESS-syndrome in children with JIA.
17
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Bernard H. Chaiken, Bernard I. Goldberg, Jack P. Segal · New England Journal of Medicine · 1950 · 158 citations
Medicine, Dermatology, Pharmacology +11